Iranian hospital Sickle Cell Disease Therapeutic Updates CME

Sickle Cell Disease (SCD) continues to be a major global public health issue and one of the world’s foremost genetic diseases . It remains a major killer of infants and children in the developing world, where an estimated 50–90 percent of infants born with SCD will die before their fifth birthday. SCD is the second most common beta globin gene defect in the UAE after Thalassemia, with 21.9% of the nationals being carriers of the HbS allele (Baysal 2005) and a prevalence of 1.9%. 30% Growth in the number of people with SCD expected globally by 2050. Join us for a CME accredited seminar on SCD and the most recent updates in its management.

For Registration: http://www.ihd.ae/registration